Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo controlled trial (2017)
Attributed to:
MICA: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.maturitas.2017.03.319
Publication URI: http://dx.doi.org/10.1016/j.maturitas.2017.03.319
Type: Journal Article/Review
Parent Publication: Maturitas